Max Healthcare Institute Limited vs Aster DM Quality Care Limited
An objective side-by-side of MAXHEALTH and ASTERDM, both in Healthcare: valuation, profitability, growth, balance sheet, ownership and share-price performance. Where one number is clearly better on its own terms (lower P/E, higher ROE), it is shaded. That is a description, not a recommendation.
Prices as of 2026-09-25 close
Latest results: MAXHEALTH Jun 2026 · ASTERDM Jun 2026
At a glance
- Max Healthcare Institute Limited is the larger company by market value, about 1.5 times the size of Aster DM Quality Care Limited.
- On trailing earnings, Max Healthcare Institute Limited trades at the lower P/E (67.7 against 207.1).
- Max Healthcare Institute Limited earns the higher return on equity (13.6% against 7.0%).
- Over three years Max Healthcare Institute Limited has grown profits faster (10% a year against -1%).
- Over the past year the share prices returned -12.6% (MAXHEALTH) and +16.7% (ASTERDM).
| Metric | Max Healthcare MAXHEALTH |
Aster DM ASTERDM |
|---|---|---|
| Size and price | ||
| Market cap | ₹98,694 Cr | ₹66,195 Cr |
| Share price | ₹1,014 | ₹759.40 |
| Valuation | ||
| P/E | 67.73 | 207.05 |
| P/B | 9.18 | 14.47 |
| EV/EBITDA | 44.08 | 84.57 |
| PEG | 6.77 | — |
| Dividend yield | 0.2% | 0.7% |
| Profitability | ||
| ROE | 13.6% | 7.0% |
| ROCE | 15.0% | 11.0% |
| Operating margin | 26.6% | 18.9% |
| Sales (TTM) | ₹8,712 Cr | ₹4,291 Cr |
| Net profit (TTM) | ₹1,457 Cr | ₹320 Cr |
| Growth | ||
| Latest quarter sales YoY | +16.7% | -32.7% |
| Latest quarter profit YoY | +4.9% | -115.2% |
| Sales CAGR 3Y | +22.0% | +16.0% |
| Profit CAGR 3Y | +10.0% | -1.0% |
| Sales CAGR 5Y | +27.0% | -12.0% |
| Profit CAGR 5Y | +60.0% | +23.0% |
| Financial strength | ||
| Debt/Equity | 0.32 | 0.49 |
| Interest cover | 7.63 | 4.88 |
| Ownership | ||
| Promoter holding | 23.7% | 53.7% |
| Promoter change (4 qtrs) | -0.03 pp | +13.33 pp |
| Price performance | ||
| Return 1M | +0.90% | -0.35% |
| Return 3M | -11.82% | -0.82% |
| Return 1Y | -12.56% | +16.73% |
| Return YTD | -2.98% | +23.11% |
| Technical condition | ||
| Technical score | 51 | 44 |
| RS rating (1-99) | 38.00 | 67.00 |
| % vs 200-DMA | -2.14% | +7.56% |
| RSI (14) | 44.14 | 45.24 |
| % from 52-week high | -17.01% | -14.80% |
